tirzepatide dosage chart units to mg Microdosing chart: complete week-by-week dosing guide Dosing?? - Very Concerned :

To view a copy of this licence, visit About this article Cite this article Sweta, Gupta, S., Bansal, S

There is a risk of dehydration if vomiting becomes frequent or persistent

SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes

Beyond FDA indications, several clinical criteria should be evaluated when considering tirzepatide initiation

"Once-Weekly Semaglutide in Adults with Overweight or Obesity." NEJM